3rd December 2020Back
Author: Nico van Schoot
Role: Business Development Manager
For the first time in the history of MEDICA, the world-leading medical trade fair, held from 16 to 19 November 2020, took place entirely online. In the current climate medical products and services are a hot topic and virtual.MEDICA gave us all an opportunity for companies to interact and share their knowledge, product offerings and experiences. Over 1,500 exhibitors took part, hailing from 63 nations. They displayed a huge variety of innovative products, amounting to over 18,300 items, in their online showrooms. Unsurprisingly there was lots of emphasis on COVID-19 especially around its diagnosis using PCR, lateral flow devices and ELISA assays all of which are heavily relevant on enzymes in their processes.
Biocatalysts Ltd has been attending MEDICA as part of the Welsh Government trade mission (Wales), for the last few years, so it was great to be able to attend this year be it only virtually. We were part of a group of 12 Welsh companies showcasing a range of products and services including cutting edge medical technology, diagnostic testing and single use medical equipment.
This year, Biocatalysts Ltd was represented by Daren Bryce, Commercial Director and myself Nico van Schoot, Business Development Manager Life Sciences. Our online booth featured brochures and presentations promoting our products and services in life sciences and in vitro diagnostics. You can still visit our booth here.
Proteocut K (PK909L), a recently launched subtilisin-type serine protease for DNA extraction applications;
Phenylalanine Dehydrogenase (P098P PheDH) a screening enzyme for Phenylketonuria (PKU);
Mannitol Dehydrogenase (M093P ManDH) for the detection of gastric disorders.
Despite the challenge of the different time-zones we had many interesting meetings with potential new clients. Discussions included making enzymes for kits for DNA extraction and In Vitro Diagnostics (IVD), to co-development of novel enzymes to scale up and contract manufacture of enzymes at industrial scale.
We at Biocatalysts Ltd continue our focus towards the Life Sciences markets looking to grow our partnerships and product offering. As part of the BRAIN group, we are able to combine our capabilities and experience in biotechnology and manufacturing to offer companies a service package, to produces speciality enzymes as raw materials at commercial scales.
An example of this it the contract manufacturing of an application-specific Taq DNA Polymerase: click here to read more.
Virtual.MEDICA gave us the opportunity to listen, and learn and to showcase our offerings to a market that is at the eye of the storm in an environment that was safe and conducive to open and honest discussions and for that we should all give thanks.